Let’s Celebrate! – Success Stories from Biopharma Excellence 🍾

Biopharma Excellence

Already in the beginning of 2019, the Biopharma Excellence has several good reasons to celebrate. The highlights with major contributions by the Biopharma Excellence team were:

  • An IND for a first-in-class product was approved by the US FDA.

  • Two products where Biopharma Excellence was making significant contributions during drug development, dossier preparation and the authorization process obtained marketing authorization in the EU.

 Together with our clients, we have been very delighted, and we congratulate the entire team to these great achievements. These are just the first success stories in this year, there are more to come! 🍾


biopharma excellence

Start a conversation today

Socials:








    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more